The corneal implants market size has grown strongly in recent years. It will grow from $1.42 billion in 2025 to $1.51 billion in 2026 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to increasing prevalence of corneal disorders, expansion of ophthalmic surgical capabilities, availability of donor corneas, rising awareness of vision correction options, improvements in surgical instrumentation.
The corneal implants market size is expected to see strong growth in the next few years. It will grow to $2.01 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing investments in regenerative ophthalmology, rising demand for vision restoration procedures, expansion of advanced eye care facilities, growing adoption of bioengineered implants, increasing focus on long-term implant durability. Major trends in the forecast period include increasing adoption of artificial corneal implants, rising use of advanced keratoplasty techniques, growing focus on biocompatible implant materials, expansion of specialized ophthalmic surgical centers, enhanced precision in corneal transplant procedures.
The anticipated rise in the prevalence of corneal disorders is poised to drive the expansion of the corneal implant market in the coming years. Corneal disorders encompass a range of medical conditions affecting the cornea, the clear, dome-shaped front surface of the eye, leading to visual impairment and discomfort. The growing incidence of corneal disorders has resulted in an increased demand for corneal implants, offering diverse solutions for treating corneal abnormalities, enhancing corneal integrity, alleviating symptoms, and improving vision. As an example, data from the Center for Disease Control (CDC) in December 2022 revealed that in the United States, the prevalence of cataracts (a corneal disorder) among individuals aged over 40 is estimated at 20.5 million, constituting approximately 17.2% of the population in that age group. Moreover, this figure is projected to surpass 30 million by the year 2028. Consequently, the upsurge in corneal disorders is a key driver for the growth of the corneal implant market.
Major companies in the corneal implants market are concentrating on developing innovative corneal contouring solutions to enhance vision correction and treat various corneal disorders. These solutions involve advanced surgical techniques and devices aimed at reshaping the cornea to improve vision and address refractive errors or corneal diseases. For instance, in June 2024, CorneaGen, a US-based developer of medical devices focused on eliminating corneal blindness, launched the Corneal Tissue Addition for Keratoplasty (CTAK). This innovative solution offers a highly effective approach to corneal contouring for keratoconic eyes. The CTAK technique involves adding donor corneal tissue to the existing cornea instead of completely replacing it. This method aims to restore the natural contour of the cornea, thereby enhancing optical clarity and improving overall visual outcomes for patients.
In January 2023, Viatris Inc., a US-based pharmaceutical and healthcare corporation, completed the acquisitions of Oyster Point Pharma and Family Life Sciences for $415 million and $280 million, respectively. Through these acquisitions, Viatris Inc. aims to expand its commercial presence and portfolio, positioning itself as a global leader in eye care, and addressing the unmet needs of patients with ophthalmic diseases and eye care professionals. Oyster Point Pharma, a US biopharmaceutical company, specializes in identifying, developing, and marketing novel treatments for eye diseases, while Family Life Sciences, an Indian drug development platform, specializes in ophthalmology.
Major companies operating in the corneal implants market are Alcon Inc., Bausch & Lomb Incorporated, Johnson & Johnson Vision, ZEISS Group, AJL Ophthalmic SA, CorNeat Vision Ltd., EyeYon Medical Ltd., Precise Bio Inc., CorneaGen, Cornea Biosciences LLC, Linkocare Life Sciences AB, MediPhacos, Coroneo Pty Ltd., KeraMed Inc., DIOPTEX Co. Ltd., HumanOptics AG, Morcher GmbH, Moria SA, DORC International BV, Aurolab (Aravind Eye Care System)
North America was the largest region in the cornea implants market in 2025. Asia Pacific is expected to be the fastest-growing region in the global cornea implants market during the forecast period. The regions covered in the corneal implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the corneal implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the corneal implants market by increasing costs of imported biomaterials, surgical instruments, preservation media, and precision manufacturing components. Ophthalmic centers in North America and Europe are most affected due to reliance on imported implants and surgical supplies, while Asia-Pacific faces higher costs in implant manufacturing and distribution. These tariffs are raising procedure costs and affecting accessibility. However, they are also encouraging localized implant production, regional tissue banking initiatives, and innovation in synthetic corneal implant development.
The corneal implants market research report is one of a series of new reports that provides corneal implants market statistics, including corneal implants industry global market size, regional shares, competitors with a corneal implants market share, detailed corneal implants market segments, market trends and opportunities, and any further data you may need to thrive in the corneal implants industry. This corneal implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Corneal implants involve a surgical intervention aimed at either replacing or enhancing a damaged or diseased cornea through the integration of an artificial or prosthetic device. This procedure is carried out to address visual impairments and alleviate associated pain.
The two primary categories of corneal implants are artificial corneal implants and human corneal implants. Artificial corneal implants are medical devices specifically designed to substitute a damaged or diseased cornea. Various techniques, such as endothelial keratoplasty and penetrating keratoplasty, are employed for corneal implants. These procedures serve diverse applications, including addressing conditions such as keratoconus, Fuchs dystrophy, infectious keratitis, corneal ulcers, among others. The implementation of corneal implant procedures typically takes place in medical facilities such as hospitals and ophthalmic centers.
The corneal implants market includes revenues earned by entities by providing corneal implantation services, including deep anterior lamellar keratoplasty (DALK) and Descemet rhexis without endothelial keratoplasty (DWEK). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The corneal implants market size is expected to see strong growth in the next few years. It will grow to $2.01 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing investments in regenerative ophthalmology, rising demand for vision restoration procedures, expansion of advanced eye care facilities, growing adoption of bioengineered implants, increasing focus on long-term implant durability. Major trends in the forecast period include increasing adoption of artificial corneal implants, rising use of advanced keratoplasty techniques, growing focus on biocompatible implant materials, expansion of specialized ophthalmic surgical centers, enhanced precision in corneal transplant procedures.
The anticipated rise in the prevalence of corneal disorders is poised to drive the expansion of the corneal implant market in the coming years. Corneal disorders encompass a range of medical conditions affecting the cornea, the clear, dome-shaped front surface of the eye, leading to visual impairment and discomfort. The growing incidence of corneal disorders has resulted in an increased demand for corneal implants, offering diverse solutions for treating corneal abnormalities, enhancing corneal integrity, alleviating symptoms, and improving vision. As an example, data from the Center for Disease Control (CDC) in December 2022 revealed that in the United States, the prevalence of cataracts (a corneal disorder) among individuals aged over 40 is estimated at 20.5 million, constituting approximately 17.2% of the population in that age group. Moreover, this figure is projected to surpass 30 million by the year 2028. Consequently, the upsurge in corneal disorders is a key driver for the growth of the corneal implant market.
Major companies in the corneal implants market are concentrating on developing innovative corneal contouring solutions to enhance vision correction and treat various corneal disorders. These solutions involve advanced surgical techniques and devices aimed at reshaping the cornea to improve vision and address refractive errors or corneal diseases. For instance, in June 2024, CorneaGen, a US-based developer of medical devices focused on eliminating corneal blindness, launched the Corneal Tissue Addition for Keratoplasty (CTAK). This innovative solution offers a highly effective approach to corneal contouring for keratoconic eyes. The CTAK technique involves adding donor corneal tissue to the existing cornea instead of completely replacing it. This method aims to restore the natural contour of the cornea, thereby enhancing optical clarity and improving overall visual outcomes for patients.
In January 2023, Viatris Inc., a US-based pharmaceutical and healthcare corporation, completed the acquisitions of Oyster Point Pharma and Family Life Sciences for $415 million and $280 million, respectively. Through these acquisitions, Viatris Inc. aims to expand its commercial presence and portfolio, positioning itself as a global leader in eye care, and addressing the unmet needs of patients with ophthalmic diseases and eye care professionals. Oyster Point Pharma, a US biopharmaceutical company, specializes in identifying, developing, and marketing novel treatments for eye diseases, while Family Life Sciences, an Indian drug development platform, specializes in ophthalmology.
Major companies operating in the corneal implants market are Alcon Inc., Bausch & Lomb Incorporated, Johnson & Johnson Vision, ZEISS Group, AJL Ophthalmic SA, CorNeat Vision Ltd., EyeYon Medical Ltd., Precise Bio Inc., CorneaGen, Cornea Biosciences LLC, Linkocare Life Sciences AB, MediPhacos, Coroneo Pty Ltd., KeraMed Inc., DIOPTEX Co. Ltd., HumanOptics AG, Morcher GmbH, Moria SA, DORC International BV, Aurolab (Aravind Eye Care System)
North America was the largest region in the cornea implants market in 2025. Asia Pacific is expected to be the fastest-growing region in the global cornea implants market during the forecast period. The regions covered in the corneal implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the corneal implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the corneal implants market by increasing costs of imported biomaterials, surgical instruments, preservation media, and precision manufacturing components. Ophthalmic centers in North America and Europe are most affected due to reliance on imported implants and surgical supplies, while Asia-Pacific faces higher costs in implant manufacturing and distribution. These tariffs are raising procedure costs and affecting accessibility. However, they are also encouraging localized implant production, regional tissue banking initiatives, and innovation in synthetic corneal implant development.
The corneal implants market research report is one of a series of new reports that provides corneal implants market statistics, including corneal implants industry global market size, regional shares, competitors with a corneal implants market share, detailed corneal implants market segments, market trends and opportunities, and any further data you may need to thrive in the corneal implants industry. This corneal implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Corneal implants involve a surgical intervention aimed at either replacing or enhancing a damaged or diseased cornea through the integration of an artificial or prosthetic device. This procedure is carried out to address visual impairments and alleviate associated pain.
The two primary categories of corneal implants are artificial corneal implants and human corneal implants. Artificial corneal implants are medical devices specifically designed to substitute a damaged or diseased cornea. Various techniques, such as endothelial keratoplasty and penetrating keratoplasty, are employed for corneal implants. These procedures serve diverse applications, including addressing conditions such as keratoconus, Fuchs dystrophy, infectious keratitis, corneal ulcers, among others. The implementation of corneal implant procedures typically takes place in medical facilities such as hospitals and ophthalmic centers.
The corneal implants market includes revenues earned by entities by providing corneal implantation services, including deep anterior lamellar keratoplasty (DALK) and Descemet rhexis without endothelial keratoplasty (DWEK). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Corneal Implants Market Characteristics
3. Corneal Implants Market Supply Chain Analysis
4. Global Corneal Implants Market Trends and Strategies
5. Corneal Implants Market Analysis of End Use Industries
7. Global Corneal Implants Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Corneal Implants Total Addressable Market (TAM) Analysis for the Market
9. Corneal Implants Market Segmentation
10. Corneal Implants Market Regional and Country Analysis
11. Asia-Pacific Corneal Implants Market
12. China Corneal Implants Market
13. India Corneal Implants Market
14. Japan Corneal Implants Market
15. Australia Corneal Implants Market
16. Indonesia Corneal Implants Market
17. South Korea Corneal Implants Market
18. Taiwan Corneal Implants Market
19. South East Asia Corneal Implants Market
20. Western Europe Corneal Implants Market
21. UK Corneal Implants Market
22. Germany Corneal Implants Market
23. France Corneal Implants Market
24. Italy Corneal Implants Market
25. Spain Corneal Implants Market
26. Eastern Europe Corneal Implants Market
27. Russia Corneal Implants Market
28. North America Corneal Implants Market
29. USA Corneal Implants Market
30. Canada Corneal Implants Market
31. South America Corneal Implants Market
32. Brazil Corneal Implants Market
33. Middle East Corneal Implants Market
34. Africa Corneal Implants Market
36. Corneal Implants Market Competitive Landscape and Company Profiles
37. Corneal Implants Market Other Major and Innovative Companies
40. Corneal Implants Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Corneal Implants Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses corneal implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for corneal implants? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The corneal implants market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Implant Type: Artificial Corneal Implant; Human Corneal Implant2) By Procedure Type: Endothelial Keratoplasty; Penetrating Keratoplasty; Other Procedure Types
3) By Application: Keratoconus; Fuchs Dystrophy; Infectious Keratitis; Corneal Ulcers; Other Applications
4) By End-User: Hospitals; Ophthalmic Center; Other End-Users
Subsegments:
1) By Artificial Corneal Implant: Keratoprosthesis; Artificial Cornea2) By Human Corneal Implant: Donor Cornea; Preserved Cornea
Companies Mentioned: Alcon Inc.; Bausch & Lomb Incorporated; Johnson & Johnson Vision; ZEISS Group; AJL Ophthalmic SA; CorNeat Vision Ltd.; EyeYon Medical Ltd.; Precise Bio Inc.; CorneaGen; Cornea Biosciences LLC; Linkocare Life Sciences AB; MediPhacos; Coroneo Pty Ltd.; KeraMed Inc.; DIOPTEX Co. Ltd.; HumanOptics AG; Morcher GmbH; Moria SA; DORC International BV; Aurolab (Aravind Eye Care System)
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Corneal Implants market report include:- Alcon Inc.
- Bausch & Lomb Incorporated
- Johnson & Johnson Vision
- ZEISS Group
- AJL Ophthalmic SA
- CorNeat Vision Ltd.
- EyeYon Medical Ltd.
- Precise Bio Inc.
- CorneaGen
- Cornea Biosciences LLC
- Linkocare Life Sciences AB
- MediPhacos
- Coroneo Pty Ltd.
- KeraMed Inc.
- DIOPTEX Co. Ltd.
- HumanOptics AG
- Morcher GmbH
- Moria SA
- DORC International BV
- Aurolab (Aravind Eye Care System)
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.51 Billion |
| Forecasted Market Value ( USD | $ 2.01 Billion |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
